
Learn more about the transformative potential of psychedelics in treating depression and mood disorders through expert insights and groundbreaking research.
Dr Goodwin is the chief medical officer at Compass Pathways, as well as the Emeritus Professor of Psychiatry and NIHR Emeritus Senior Investigator at the University of Oxford, UK.

Learn more about the transformative potential of psychedelics in treating depression and mood disorders through expert insights and groundbreaking research.